Austin Aerts Sells 5,056 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA) CFO Austin Aerts sold 5,056 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $7.57, for a total value of $38,273.92. Following the transaction, the chief financial officer now directly owns 298,665 shares in the company, valued at approximately $2,260,894.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Austin Aerts also recently made the following trade(s):

• On Wednesday, August 7th, Austin Aerts sold 6,760 shares of Sera Prognostics stock. The shares were sold at an average price of $7.42, for a total value of $50,159.20.

Sera Prognostics Trading Up 1.4 %

SERA stock opened at $7.40 on Wednesday. Sera Prognostics, Inc. has a 1-year low of $1.56 and a 1-year high of $12.35. The business’s 50 day simple moving average is $7.18 and its 200 day simple moving average is $8.30. The firm has a market capitalization of $241.64 million, a PE ratio of -6.92 and a beta of 1.03.

Sera Prognostics (NASDAQ:SERA) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02). The company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.08 million. Sera Prognostics had a negative return on equity of 46.71% and a negative net margin of 11,843.79%. During the same period last year, the firm earned ($0.34) earnings per share. As a group, sell-side analysts predict that Sera Prognostics, Inc. will post -0.95 EPS for the current fiscal year.

Institutional Trading of Sera Prognostics

Several hedge funds and other institutional investors have recently modified their holdings of SERA. StepStone Group LP acquired a new stake in Sera Prognostics during the fourth quarter worth approximately $61,000. Sanders Morris Harris LLC acquired a new stake in Sera Prognostics during the 1st quarter worth approximately $174,000. AWM Investment Company Inc. boosted its stake in Sera Prognostics by 56.0% in the 1st quarter. AWM Investment Company Inc. now owns 584,664 shares of the company’s stock valued at $5,320,000 after purchasing an additional 209,762 shares during the period. RA Capital Management L.P. bought a new stake in Sera Prognostics in the 1st quarter valued at $18,420,000. Finally, Twelve Points Wealth Management LLC acquired a new position in Sera Prognostics in the 2nd quarter valued at $257,000. Institutional investors own 54.64% of the company’s stock.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.